Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery, ATCC Sign Distribution Deal for Cell Lines

NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.

ATCC will provide to its academic and not-for-profit customers certain Horizon products as part of, or in conjunction with, ATCC's Tumor Cell Panels. The deal is for non-commercial use only and excludes distribution in Japan or distribution of X-Man isogenic cell lines in isolation.

Financial and other terms of the deal were not disclosed.

Horizon offers more than 450 X-Man cell lines, which it said are the world's first source of genetically defined and patient-relevant human cell lines.

"The ability to work with accurate disease model cell lines is of great benefit, particularly in oncology research where many mutations studied are rare, and reliable sources of patient-derived cell lines are scarce," ATCC CEO Raymond Cypess said in a statement.

The Scan

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.